Literature DB >> 12765966

Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice.

Rohit N Kulkarni1, Katrine Almind, H Joseph Goren, Jonathon N Winnay, Kohjiro Ueki, Terumasa Okada, C Ronald Kahn.   

Abstract

Type 2 diabetes is a complex disease in which genetic and environmental factors interact to produce alterations in insulin action and insulin secretion, leading to hyperglycemia. To evaluate the influence of genetic background on development of diabetes in a genetically susceptible host, we generated mice that are double heterozygous (DH) for knockout of the insulin receptor and insulin receptor substrate-1 on three genetic backgrounds (C57BL/6 [B6], 129Sv, and DBA). Although DH mice on all backgrounds showed insulin resistance, their phenotypes were dramatically different. B6 DH mice exhibited marked hyperinsulinemia and massive islet hyperplasia and developed early hyperglycemia, with 85% overtly diabetic by 6 months. By contrast, 129Sv DH mice showed mild hyperinsulinemia and minimal islet hyperplasia, and < 2% developed diabetes. DBA mice had slower development of hyperglycemia, intermediate insulin levels, and evidence of islet degeneration, with 64% developing diabetes. Thus, mice carrying the same genetic defects on different backgrounds exhibited the full spectrum of abnormalities observed in humans with type 2 diabetes, which allowed for identification of potential loci that promote development of the diabetic phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765966     DOI: 10.2337/diabetes.52.6.1528

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  48 in total

1.  Hepatocyte growth factor ameliorates hyperglycemia and corrects β-cell mass in IRS2-deficient mice.

Authors:  Juan C Alvarez-Perez; Taylor C Rosa; Gabriella P Casinelli; Shelley R Valle; Jayalakshmi Lakshmipathi; Carolina Rosselot; Francisco Rausell-Palamos; Rupangi C Vasavada; Adolfo García-Ocaña
Journal:  Mol Endocrinol       Date:  2014-12

2.  Pancreatic function in carboxyl-ester lipase knockout mice.

Authors:  Mette Vesterhus; Helge Raeder; Amarnath J Kurpad; Dan Kawamori; Anders Molven; Rohit N Kulkarni; C Ronald Kahn; Pål Rasmus Njølstad
Journal:  Pancreatology       Date:  2010-08-19       Impact factor: 3.996

3.  Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

Authors:  Nell Marty; Michel Dallaporta; Marc Foretz; Martine Emery; David Tarussio; Isabelle Bady; Christophe Binnert; Friedrich Beermann; Bernard Thorens
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Uncoupling modifier genes from uncoupling protein 2 in pancreatic beta-cells.

Authors:  Rohit N Kulkarni
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

5.  Insulin-like Growth Factor 2 Overexpression Induces β-Cell Dysfunction and Increases Beta-cell Susceptibility to Damage.

Authors:  Alba Casellas; Cristina Mallol; Ariana Salavert; Veronica Jimenez; Miquel Garcia; Judith Agudo; Mercè Obach; Virginia Haurigot; Laia Vilà; Maria Molas; Ricardo Lage; Meritxell Morró; Estefania Casana; Jesús Ruberte; Fatima Bosch
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

6.  Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.

Authors:  Yau-Sheng Tsai; Hyo-Jeong Kim; Nobuyuki Takahashi; Hyung-Suk Kim; John R Hagaman; Jason K Kim; Nobuyo Maeda
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 7.  Growth factor control of pancreatic islet regeneration and function.

Authors:  Anke Assmann; Charlotte Hinault; Rohit N Kulkarni
Journal:  Pediatr Diabetes       Date:  2008-09-19       Impact factor: 4.866

8.  A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease.

Authors:  Marcelo A Mori; Manway Liu; Olivier Bezy; Katrine Almind; Hagit Shapiro; Simon Kasif; C Ronald Kahn
Journal:  Diabetes       Date:  2010-08-16       Impact factor: 9.461

9.  Insulin signaling regulates mitochondrial function in pancreatic beta-cells.

Authors:  Siming Liu; Terumasa Okada; Anke Assmann; Jamie Soto; Chong Wee Liew; Heiko Bugger; Orian S Shirihai; E Dale Abel; Rohit N Kulkarni
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

10.  Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents.

Authors:  Senta Georgia; Charlotte Hinault; Dan Kawamori; Jiang Hu; John Meyer; Murtaza Kanji; Anil Bhushan; Rohit N Kulkarni
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.